BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2994662)

  • 1. Purification of the epidermal growth factor receptor by tyrosine-Sepharose affinity chromatography.
    Akiyama T; Kadooka T; Ogawara H
    Biochem Biophys Res Commun; 1985 Aug; 131(1):442-8. PubMed ID: 2994662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoaffinity purification of the epidermal growth factor receptor. Stoichiometry of binding and kinetics of self-phosphorylation.
    Weber W; Bertics PJ; Gill GN
    J Biol Chem; 1984 Dec; 259(23):14631-6. PubMed ID: 6094567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autophosphorylation and protein kinase C phosphorylation of the epidermal growth factor receptor. Effect on tyrosine kinase activity and ligand binding affinity.
    Downward J; Waterfield MD; Parker PJ
    J Biol Chem; 1985 Nov; 260(27):14538-46. PubMed ID: 2997213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Large-scale purification and characterisation of a recombinant epidermal growth-factor receptor protein-tyrosine kinase. Modulation of activity by multiple factors.
    McGlynn E; Becker M; Mett H; Reutener S; Cozens R; Lydon NB
    Eur J Biochem; 1992 Jul; 207(1):265-75. PubMed ID: 1321046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal growth factor-receptor-protein kinase interactions.
    Cohen S; Carpenter G; King L
    Prog Clin Biol Res; 1981; 66 Pt A():557-67. PubMed ID: 6273929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amiloride directly inhibits growth factor receptor tyrosine kinase activity.
    Davis RJ; Czech MP
    J Biol Chem; 1985 Feb; 260(4):2543-51. PubMed ID: 2982824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. cAMP-dependent protein kinase stimulates epidermal growth factor-dependent phosphorylation of epidermal growth factor receptors.
    Ghosh-Dastidar P; Fox CF
    J Biol Chem; 1984 Mar; 259(6):3864-9. PubMed ID: 6323445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal growth factor receptors in the human glioblastoma cell line SF268 differ from those in epidermoid carcinoma cell line A431.
    Westphal M; Harsh GR; Rosenblum ML; Hammonds RG
    Biochem Biophys Res Commun; 1985 Oct; 132(1):284-9. PubMed ID: 2998356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different responses to EGF in two human carcinoma cell lines, A431 and UCVA-1, possessing high numbers of EGF receptors.
    Gamou S; Kim YS; Shimizu N
    Mol Cell Endocrinol; 1984 Sep; 37(2):205-13. PubMed ID: 6092175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered epidermal growth factor (EGF)-stimulated protein kinase activity in variant A431 cells with altered growth responses to EGF.
    Buss JE; Kudlow JE; Lazar CS; Gill GN
    Proc Natl Acad Sci U S A; 1982 Apr; 79(8):2574-8. PubMed ID: 6283535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification of insulin-like growth factor I receptor from human placental membranes.
    LeBon TR; Jacobs S; Cuatrecasas P; Kathuria S; Fujita-Yamaguchi Y
    J Biol Chem; 1986 Jun; 261(17):7685-9. PubMed ID: 3011795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidermal growth factor-receptor-protein kinase interactions. Co-purification of receptor and epidermal growth factor-enhanced phosphorylation activity.
    Cohen S; Carpenter G; King L
    J Biol Chem; 1980 May; 255(10):4834-42. PubMed ID: 6246084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-kinase phosphorylates the epidermal growth factor receptor and reduces its epidermal growth factor-stimulated tyrosine protein kinase activity.
    Cochet C; Gill GN; Meisenhelder J; Cooper JA; Hunter T
    J Biol Chem; 1984 Feb; 259(4):2553-8. PubMed ID: 6321473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the interaction of 5'-p-fluorosulfonylbenzoyl adenosine with the epidermal growth factor receptor/protein kinase in A431 cell membranes.
    Buhrow SA; Cohen S; Garbers DL; Staros JV
    J Biol Chem; 1983 Jun; 258(12):7824-7. PubMed ID: 6305956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification of denatured epidermal growth factor-receptor from A431 human epidermoid carcinoma cells.
    Decker S
    Arch Biochem Biophys; 1984 Feb; 228(2):621-6. PubMed ID: 6320745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-promoting phorbol diesters mediate phosphorylation of the epidermal growth factor receptor.
    Davis RJ; Czech MP
    J Biol Chem; 1984 Jul; 259(13):8545-9. PubMed ID: 6330113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Properties of receptors for epidermal growth factor in detergent solution: evidence for heterogeneous aggregated states.
    Linsley PS; Fox CF
    J Supramol Struct; 1980; 14(4):511-25. PubMed ID: 6264235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of the epidermal growth factor receptor kinase with the detergent-insoluble cytoskeleton of A431 cells.
    Landreth GE; Williams LK; Rieser GD
    J Cell Biol; 1985 Oct; 101(4):1341-50. PubMed ID: 2413042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibodies against the human epidermal growth factor receptor from A431 cells. Isolation, characterization, and use in the purification of active epidermal growth factor receptor.
    Parker PJ; Young S; Gullick WJ; Mayes EL; Bennett P; Waterfield MD
    J Biol Chem; 1984 Aug; 259(15):9906-12. PubMed ID: 6086658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solubilization and isolation of the human placenta receptor for epidermal growth factor-urogastrone.
    Hock RA; Nexø E; Hollenberg MD
    J Biol Chem; 1980 Nov; 255(22):10737-43. PubMed ID: 6253486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.